Vitamin A derivative provides clues to better breast cancer drugs
Thursday, June 25, 2009 - 12:21
in Health & Medicine
Retinoic acid, a derivative of vitamin A, could lead researchers to a new set of drug targets for treating breast cancer, researchers from the University of Chicago report in the June 25, 2009, issue of the journal Cell.